HSP90 stabilizes B-cell receptor kinases in a multi-client interactome: PU-H71 induces CLL apoptosis in a cytoprotective microenvironment
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HSP90 stabilizes B-cell receptor kinases in a multi-client interactome: PU-H71 induces CLL apoptosis in a cytoprotective microenvironment
Authors
Keywords
-
Journal
ONCOGENE
Volume 36, Issue 24, Pages 3441-3449
Publisher
Springer Nature
Online
2017-01-24
DOI
10.1038/onc.2016.494
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic lymphocytic leukemia (CLL)-Then and now
- (2016) Kanti R. Rai et al. AMERICAN JOURNAL OF HEMATOLOGY
- BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia
- (2016) Andrea Haerzschel et al. ANNALS OF HEMATOLOGY
- An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia
- (2015) J. Sharman et al. BLOOD
- Hypermorphic mutation of phospholipase C, 2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation
- (2015) T.-M. Liu et al. BLOOD
- Pharmacoproteomics identifies combinatorial therapy targets for diffuse large B cell lymphoma
- (2015) Rebecca L. Goldstein et al. JOURNAL OF CLINICAL INVESTIGATION
- Detecting Germline PTEN Mutations Among At-Risk Patients With Cancer: An Age- and Sex-Specific Cost-Effectiveness Analysis
- (2015) Joanne Ngeow et al. JOURNAL OF CLINICAL ONCOLOGY
- Non-coding recurrent mutations in chronic lymphocytic leukaemia
- (2015) Xose S. Puente et al. NATURE
- Mutations driving CLL and their evolution in progression and relapse
- (2015) Dan A. Landau et al. NATURE
- A Hyperactive Signalosome in Acute Myeloid Leukemia Drives Addiction to a Tumor-Specific Hsp90 Species
- (2015) Hongliang Zong et al. Cell Reports
- The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-κB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells
- (2015) Elisabeth J. Walsby et al. Oncotarget
- Functional characterization of BTK C481S mutation that confers ibrutinib resistance: exploration of alternative kinase inhibitors
- (2014) S Cheng et al. LEUKEMIA
- Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib
- (2014) Jennifer A. Woyach et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ibrutinib Resistance in Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective targeting of the stress chaperome as a therapeutic strategy
- (2014) Tony Taldone et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
- (2013) Dan A. Landau et al. CELL
- BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activity
- (2013) S Cheng et al. LEUKEMIA
- Through thick and thin
- (2013) Olaf S Andersen Nature Chemical Biology
- Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
- (2013) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Pathways: Targeting Hsp90--Who Benefits and Who Does Not
- (2012) M. Scaltriti et al. CLINICAL CANCER RESEARCH
- Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies
- (2012) Ranjana H. Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
- (2012) Marcus Dühren-von Minden et al. NATURE
- SYK inhibition and response prediction in diffuse large B-cell lymphoma
- (2011) S. Cheng et al. BLOOD
- Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches
- (2011) Rachel E. Hayden et al. LEUKEMIA & LYMPHOMA
- Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90
- (2011) Kamalika Moulick et al. Nature Chemical Biology
- Nurture versus Nature: The Microenvironment in Chronic Lymphocytic Leukemia
- (2011) J. A. Burger Hematology-American Society of Hematology Education Program
- 17-DMAG targets the nuclear factor- B family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition
- (2010) E. Hertlein et al. BLOOD
- Activities of SYK and PLC 2 Predict Apoptotic Response of CLL Cells to SRC Tyrosine Kinase Inhibitor Dasatinib
- (2010) Z. Song et al. CLINICAL CANCER RESEARCH
- Expression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemia
- (2010) Olga Grzybowska-Izydorczyk et al. EUROPEAN JOURNAL OF CANCER
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
- (2010) R. Eric Davis et al. NATURE
- Geldanamycin-induced Lyn dissociation from aberrant Hsp90-stabilized cytosolic complex is an early event in apoptotic mechanisms in B-chronic lymphocytic leukemia
- (2008) L. Trentin et al. BLOOD
- AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance
- (2008) K. Balakrishnan et al. BLOOD
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now